Jack Meehan
Stock Analyst at Barclays
(3.10)
# 972
Out of 4,829 analysts
135
Total ratings
70.73%
Success rate
21.1%
Average return
Main Sectors:
Stocks Rated by Jack Meehan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LH Labcorp Holdings | Maintains: Equal-Weight | $240 → $250 | $250.94 | -0.37% | 15 | Apr 30, 2025 | |
| A Agilent Technologies | Maintains: Underweight | $120 → $125 | $115.55 | +8.18% | 20 | Feb 28, 2024 | |
| WAT Waters | Maintains: Equal-Weight | $275 → $288 | $366.67 | -21.46% | 10 | Aug 3, 2023 | |
| AVTR Avantor | Initiates: Overweight | $33 | $13.00 | +153.85% | 3 | Mar 3, 2021 | |
| ILMN Illumina | Initiates: Underweight | $325 | $81.57 | +298.43% | 8 | Mar 3, 2021 | |
| INMD InMode | Maintains: Overweight | $18 → $19 | $15.00 | +26.67% | 3 | Aug 17, 2020 | |
| DGX Quest Diagnostics | Maintains: Equal-Weight | $93 → $99 | $175.90 | -43.72% | 7 | Apr 23, 2020 | |
| ICLR ICON Public Limited Company | Maintains: Overweight | $170 → $180 | $140.22 | +28.37% | 2 | Apr 23, 2020 | |
| MYGN Myriad Genetics | Maintains: Underweight | $14 → $10 | $4.25 | +135.29% | 8 | Mar 26, 2020 | |
| IQV IQVIA Holdings | Maintains: Overweight | $192 → $166 | $156.13 | +6.32% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $43 | $58.81 | -26.88% | 9 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $170 → $154 | $143.08 | +7.63% | 7 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $430 | $256.68 | +67.52% | 6 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $430 | $252.64 | +70.20% | 6 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | n/a | $37.42 | - | 10 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $52 → $48 | $40.26 | +19.23% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $720 → $680 | $1,174.59 | -42.11% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $30 | $110.76 | -72.91% | 3 | Oct 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $295 → $300 | $432.59 | -30.65% | 5 | Mar 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $40 | $1.52 | +2,531.58% | 1 | Dec 11, 2017 |
Labcorp Holdings
Apr 30, 2025
Maintains: Equal-Weight
Price Target: $240 → $250
Current: $250.94
Upside: -0.37%
Agilent Technologies
Feb 28, 2024
Maintains: Underweight
Price Target: $120 → $125
Current: $115.55
Upside: +8.18%
Waters
Aug 3, 2023
Maintains: Equal-Weight
Price Target: $275 → $288
Current: $366.67
Upside: -21.46%
Avantor
Mar 3, 2021
Initiates: Overweight
Price Target: $33
Current: $13.00
Upside: +153.85%
Illumina
Mar 3, 2021
Initiates: Underweight
Price Target: $325
Current: $81.57
Upside: +298.43%
InMode
Aug 17, 2020
Maintains: Overweight
Price Target: $18 → $19
Current: $15.00
Upside: +26.67%
Quest Diagnostics
Apr 23, 2020
Maintains: Equal-Weight
Price Target: $93 → $99
Current: $175.90
Upside: -43.72%
ICON Public Limited Company
Apr 23, 2020
Maintains: Overweight
Price Target: $170 → $180
Current: $140.22
Upside: +28.37%
Myriad Genetics
Mar 26, 2020
Maintains: Underweight
Price Target: $14 → $10
Current: $4.25
Upside: +135.29%
IQVIA Holdings
Mar 26, 2020
Maintains: Overweight
Price Target: $192 → $166
Current: $156.13
Upside: +6.32%
Mar 26, 2020
Maintains: Equal-Weight
Price Target: $51 → $43
Current: $58.81
Upside: -26.88%
Mar 26, 2020
Maintains: Equal-Weight
Price Target: $170 → $154
Current: $143.08
Upside: +7.63%
Mar 26, 2020
Maintains: Overweight
Price Target: $435 → $430
Current: $256.68
Upside: +67.52%
Mar 26, 2020
Maintains: Overweight
Price Target: $435 → $430
Current: $252.64
Upside: +70.20%
Mar 26, 2020
Downgrades: Equal-Weight
Price Target: n/a
Current: $37.42
Upside: -
Mar 26, 2020
Upgrades: Overweight
Price Target: $52 → $48
Current: $40.26
Upside: +19.23%
Mar 26, 2020
Upgrades: Equal-Weight
Price Target: $720 → $680
Current: $1,174.59
Upside: -42.11%
Oct 2, 2019
Maintains: Underweight
Price Target: $28 → $30
Current: $110.76
Upside: -72.91%
Mar 18, 2019
Maintains: Overweight
Price Target: $295 → $300
Current: $432.59
Upside: -30.65%
Dec 11, 2017
Initiates: Equal-Weight
Price Target: $40
Current: $1.52
Upside: +2,531.58%